NCT06541028Recruiting
Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)
Reducing Stigma in People Who Inject Drugs With HIV Using a Rapid Start Antiretroviral Therapy Intervention (RS-ART)
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3). The research will not impact the type of medication and dose prescribed, but rather, how soon providers are able to prescribe ART after diagnosis. The focus of this registration is Aim 3.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 135 (estimated)
- First submitted
- 2 Aug 2024
- Start date
- 4 Nov 2025
- Primary completion date
- May 2028
- Lead sponsor
- Yale University
- Diseases
- HIV
- NCT number
- NCT06541028
What you commit to
- Study type: Interventional
- Planned participants: 135
- From 4 Nov 2025 to the primary completion date, May 2028
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- PWID in general population:
- Be a PWID from the general population enrolling into ART services at one of the study's HIV clinics. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these patients may be diagnosed with Opioid Use Disorder (OUD).
- Provide informed consent.
- HIV clinicians prescribing ART
- Be the HIV clinician who prescribes ART for a PWID in one of the selected clinics.
- Be willing to use the RS-ART protocol.
- Be at least 18 years old. No minors below age 18 will be enrolled in the study.
- Provide informed consent.
- PWID in prison population:
- Be a PWID enrolling into ART services at Kajang prison. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these patients may be diagnosed with Opioid Use Disorder (OUD).
- Provide informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kajang Prison Coordinator of this site? Confirm its status | Kajang | Malaysia | Recruiting |
| Centre of Excellence for Research in AIDS (CERiA) - University of Malaya Coordinator of this site? Confirm its status | Kuala Lumpur | Malaysia | Active, not recruiting |
| Primary Healthcare Centers Coordinator of this site? Confirm its status | Kuala Lumpur | Malaysia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.